Détention brevets de la classe A61K 31/165

Brevets de cette classe: 3647

Historique des publications depuis 10 ans

277
273
289
318
302
283
233
245
210
142
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
20924
51
Newron Pharmaceuticals S.p.A.
56
37
LTS Lohmann Therapie-Systeme AG
681
29
Murray and Poole Enterprises Limited
30
27
Novartis AG
10172
26
Les Laboratoires Servier
498
25
Allergan, Inc.
2146
22
The General Hospital Corporation
4895
20
Axsome Malta Ltd.
79
20
Vanda Pharmaceuticals, Inc.
392
19
President and Fellows of Harvard College
6118
17
BIAL - Portela & CA, S.A.
214
17
Dana-Farber Cancer Institute, Inc.
2677
16
Board of Regents, The University of Texas System
6177
15
Children's Medical Center Corporation
1971
15
Indiana University Research and Technology Corporation
780
15
Jazz Pharmaceuticals Research UK Limited
259
15
The United States of America, as represented by the Secretary, Department of Health and Human Services
3019
14
Brightseed, Inc.
60
14
The Board of Trustees of the Leland Stanford Junior University
6722
13
Autres propriétaires 3220